Design and rationale of Clopidogrel as Adjunctive Reperfusion Therapy–Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial
- 28 February 2005
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 149 (2) , 227-233
- https://doi.org/10.1016/j.ahj.2004.11.006
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes The Global Registry of Acute Coronary Events (GRACE)European Heart Journal, 2003
- Aspirin Plus Coumarin Versus Aspirin Alone in the Prevention of Reocclusion After Fibrinolysis for Acute Myocardial InfarctionCirculation, 2002
- Reperfusion for ST-Segment Elevation Myocardial InfarctionCirculation, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Abciximab Facilitates the Rate and Extent of ThrombolysisCirculation, 1999
- TNK–Tissue Plasminogen Activator Compared With Front-Loaded Alteplase in Acute Myocardial InfarctionCirculation, 1998
- The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study. Results of the APRICOT Study.Circulation, 1993
- Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group.Circulation, 1990
- Six- and twelve-month follow-up of the phase I thrombolysis in myocardial infarction (TIMI) trialThe American Journal of Cardiology, 1988